Ceftriaxone-Induced Fatal Anaphylaxis Shock at An Emergency Department: A Case Report
Ceftriaxone-Induced Fatal Anaphylaxis Shock at An Emergency Department: A Case Report
Ceftriaxone-Induced Fatal Anaphylaxis Shock at An Emergency Department: A Case Report
75
INTRODUCTION
Ceftriaxone is a 3rd generation cephalosporin antibiotic, commonly used to treat
infections, both g-positive and -negative bacteria. It can cause a range of hypersensitivity
reactions and should be contraindicated in patients with known hypersensitivity.[1]
Incidence of anaphylaxis caused by ceftriaxone is rare. Anaphylaxis could be caused
by drugs such as antibiotics, opioids, non-steroidal anti-inflammatory drugs (NSAIDs)
and muscle relaxants. Sign and symptoms of anaphylaxis are variable and can range
from mild skin lesion to fatal reaction. It affects different organs and its most severe
form results in anaphylaxis. If patients have previous experience of hypersensitivity
reactions to penicillin and other beta lactam antibacterial agents, they might have
greater risk of hypersensitivity to Ceftriaxone.
Case Presentation
A 31-years old Arab female patient was admitted to the emergency (ER) department
due to influenza symptoms. She weighs 65 kg and 165 cm in height. Based on the
Publishing Partner : EManuscript [www.emanuscript.in] This is an open access article distributed under the terms of the Creative Commons
Attribution-NonCommercial-ShareAlike 4.0 License
Journal of Pharmacy Practice and Community Medicine Vol. 3 ● Issue 4 ● Oct-Dec 2017 ● www.jppcm.org 299
Ceftriaxone-induced fatal anaphylaxis shock
examination, patient was suspected having pneumonia. following IM administration with mean maximum plasma
She has history of celiac disease. History taking showed concentrations occurring between 2 and 3 h post-dose.
that she does not have penicillin allergy in the past, no Multiple IV or IM doses ranging from 0.5 to 2 g at 12-
history of any other concomitant medications, and no to 24-h intervals resulted in 15% to 36% accumulation
other comorbidities. Upon admission, patient was febrile of Ceftriaxone above single dose values.[3] Ceftriaxone is
with 38 degree Celsius. At ER department she was given reversibly bound to human plasma proteins and crosses
ceftriaxone 1 g intravenous (IV) and within 15 min the the blood placenta barrier.
patient started to complain from shortness of breath
and bronchospasm started with severe drop in the blood Ceftriaxone induced anaphylaxis is a rare case but the
pressure (BP); the vital signs i.e. BP was 65/52 mmHg, incidence of hypersensitivity skin reactions was reported
normal blood oxygen saturation levels (SpO2) was 87%, between 1 to 3%.[4] Cephalosporin reactions can be divided
and respiratory rate (RR) was 31/min. No sensitivity test into in two categories: (1) immediate which develop within
was taken prior to the administration of the medicine. 1 h after drug administration, and (2) nonimmediate which
Anaphylactic reaction was suspected. develop after 1 h of drug administration.[5] Anaphylaxis
can happen in patients with immunoglobulin E-mediated
Action: Ceftriaxone was stopped immediately. Aggressive allergy.[6,7] Anaphylaxis is an acute life threatening reaction.
management started immediately with resuscitative Antibiotic skin testing is not normally done in a patients
treatment. Patient was put on high flow oxygen via face without a history of allergy including food allergy. Patients
mask and was administered the following: injection (Inj.) planned to take antibiotic therapy especially intravenous
adrenaline 500 micrograms intramuscular (IM) (0.5 mL), route or intramuscular should apply the penicillin skin
Inj. hydrocortisone slow IV 200 mg, ringer lactate IV, Inj. test. If patient sensitive to penicillin thus, there is cross
pheniramine 1mg/kg slow IV and Inj ranitidine 1mg/kg sensitivity with cephalosporin to develop allergy. Fast
IV along with two boluses of normal saline. She was given recognition and appropriate aggressive treatment using the
tepid water sponging to control the fever. Airway, Breathing, Circulation, Disability, and Exposure
(ABCDE) approach are important for the successful
Evaluation: On the same day, after 6 hrs of resuscitative management of anaphylaxis. [8] Patients must constantly
treatment, patient had pulse rate of 82/min; BP 100/71 be observed and followed up. Healthcare professionals
mmHg and RR 21/min. Patients laboratory investigations are encouraged to refer to international guidelines e.g.
showed raised monocyte count: UK guidelines for emergency treatment of anaphylactic
reactions for emergency treatment of anaphylaxis [8] and
Monocyte % = 13.70 % (normal range: 0.00 - 12.00) other useful websites e.g. www.resus.org.uk, www.bsaci.org.
www.eaaci.net, www.cochrane.org. www.bestbets.org.
Monocytes = 1.16 10e3/uL (normal range: 0.00 - 0.90). Patient need to know the allergen responsible, know how
to avoid situations and be able to recognize the early
Other laboratory values: symptoms of anaphylaxis.
Cite this article as: Imam EA and Ibrahim MIM. Ceftriaxone-Induced Fatal Anaphylaxis Shock at an Emergency Department:
A Case Report. J Pharm Pract Community Med. 2017;3(4):299-301.
Journal of Pharmacy Practice and Community Medicine Vol. 3 ● Issue 4 ● Oct-Dec 2017 ● www.jppcm.org 301